David K. Lam, MD, DDS, PhD, FRCDC
Tuesday, March 31st – 2:00 pm to 4:00 pm – 2 CE CREDIT HOURS

NEW DENTIST: $45                   RDH/STAFF: FREE

 “Oral Pre-Cancer and Cancer: from Screening to Survivorship”

Oral cancer is readily treatable when diagnosed early. The dental health care professional is often the first to be consulted by a patient with signs and symptoms of oral cancer. Non healing ulcers, red lesions, red and white lesions, white lesions and irregular masses require either further investigation or close follow-up to ensure appropriate management. Any oral lesion that does not heal and is not yet diagnosed as some other mucosal abnormality should be suspicious for a premalignant or malignant lesion. Biopsy or referral for biopsy by the dentist can significantly reduce the delay in diagnosis, and improve outcomes.  We will discuss practical recommendations and pearls for screening and managing patients with suspicious lesions in the general practice setting, including:

Course Objectives:

  • How to recognize premalignant lesions;
  • When to monitor, biopsy or refer suspicious lesions; and
  • An overview of the multidisciplinary management of the oral cancer patient from diagnosis, metastatic work-up and tumor board review, to treatment with surgery, radiation therapy, and/or chemotherapy;

David K. Lam, MD, DDS, PhD, FRCDC          

Dr. Lam specializes in the comprehensive surgical management of patients with cancer, pathology, and trigeminal nerve injury. His research and clinical programs are closely integrated, and his research addresses the challenges he faces in the clinical management of patients with cancer.

He obtained his DDS with Honors from the University of Toronto and subsequently obtained a PhD in the Collaborative Program in Neuroscience and Oral & Maxillofacial Surgery Specialty Certificate from the same institution. He earned his MD from the University of California, Davis and completed a Postdoctoral Neuroscience Research Fellowship, as well as a Surgical Fellowship in Maxillofacial Oncology and Reconstructive Surgery at the University of California, San Francisco.

He is a Diplomate of the American Board of Oral & Maxillofacial Surgery and a Fellow (OMFS) in the Royal College of Dentists in Canada. His funded research focuses on the models and pathways concerning pain associated with head and neck cancer. In addition to funding on research, education and training grants, Lam has published and presented internationally, nationally and locally on a variety of topics relevant to his research and clinical interests.